Am Soc Clin Oncol Educ Book

1. MCKAY RR, Tipirneni A, Bangs R, Guercio BJ, et al
   Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms.
   Am Soc Clin Oncol Educ Book. 2026;46:e516902.
   

   >> Share

   
   

   
   Ann Oncol

2. ROUPRET M
   Reply to Letter to the Editor: 'ALBAN (GETUG-AFU 37): a phase 3, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guerin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle invasive bladd
   Ann Oncol. 2026 Mar 3:S0923-7534(26)00046-3. doi: 10.1016/j.annonc.2026.
   

   >> Share

   
   

   
   Arch Esp Urol

3. YANG Q, Zhou D, Beasley A, Liu Y, et al
   Identification of SLC3A2 as a Potential Therapeutic Target of Ferroptosis in Bladder Cancer.
   Arch Esp Urol. 2026;79:36-48.
   

   >> Share

   
   

   
   Biochim Biophys Acta Rev Cancer

4. ZHOU M, Xue X, Li H, Chen Z, et al
   Decoding the metabolic-immune axis for novel therapeutics in bladder cancer.
   Biochim Biophys Acta Rev Cancer. 2026 Mar 2:189569.
   

   >> Share

   
   

   
   BJU Int

5. BARRETTA A, Piazza P, Catanzaro C, Mottaran A, et al
   Is there still a role for ureteric frozen section analysis during radical cystectomy?
   BJU Int. 2026;137:659-666.
   

   >> Share

   
   

   
   Cancer Sci

6. YAMADA S, Sato M, Osawa T, Harabayashi T, et al
   Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan.
   Cancer Sci. 2026;117:739-748.
   

   >> Share

   
   

   
   Int J STD AIDS

7. NOGUEIRA CM, Machado C, Santos RB, Faustino AS, et al
   Infiltrated penile papules as a cutaneous manifestation of disseminated BCGitis: A rare dermatologic presentation.
   Int J STD AIDS. 2026;37:444-446.
   

   >> Share

   
   

   
   Int J Urol

8. SANO T, Ohe C, Motoki Y, Nakamoto T, et al
   Prognostic Significance of Tertiary Lymphoid Structure-Like Lymphocyte Aggregates in Routine Histopathological Examination in Bladder Cancer.
   Int J Urol. 2026;33:e70392.
   

   >> Share

   
   

   
   Investig Clin Urol

9. BANG S, Joo SM, Kim DK, Kwon JK, et al
   Preoperative selective arterial embolization followed by transurethral resection of bladder tumor for large bladder tumors: Early clinical experiences.
   Investig Clin Urol. 2026;67:162-169.
   

   >> Share

   
   

   
   J Med Econ

10. YANG M, Chai X, Ye D, Zhao A, et al
    Budget impact model of nadofaragene firadenovec for the treatment of high-risk non-muscle-invasive bladder cancer that is unresponsive to Bacillus Calmette-Guerin immunotherapy.
    J Med Econ. 2026;29:672-687.
    

    >> Share

    
    

    
    J Transl Med

11. WENG HW, Ting HK, Wang HH, Peng TJ, et al
    Targeting neuropilin-1 and neutralizing interleukin-6 inhibits cancer stem cell formation in bladder cancer cells.
    J Transl Med. 2026 Mar 4. doi: 10.1186/s12967-026-07943.
    

    >> Share

    
    

    
    Mol Cancer Ther

12. STARRETT JH, Allen EL, Neal M, Iyer S, et al
    Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity.
    Mol Cancer Ther. 2026;25:408-415.
    

    >> Share

    
    

    
    Support Care Cancer

13. GIRGIN R, Mungan NA
    Turkish urologists' knowledge and attitudes on lifestyle advice for bladder cancer: a national survey.
    Support Care Cancer. 2026;34:260.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share